Login / Signup

The "real-world" efficacy and safety of DAAs for the treatment of HCV patients throughout Japan.

Shinya MaekawaNobuyuki Enomoto
Published in: Journal of gastroenterology (2018)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • hepatitis c virus
  • prognostic factors
  • patient reported outcomes
  • human immunodeficiency virus
  • patient reported
  • smoking cessation